ALAHIST - 50991-814-15 - (Brompheniramine Maleate, Phenylephrine Hydrochloride, Dextromethorphan Hydrobromide)

Alphabetical Index


Drug Information of ALAHIST

Product NDC: 50991-814
Proprietary Name: ALAHIST
Non Proprietary Name: Brompheniramine Maleate, Phenylephrine Hydrochloride, Dextromethorphan Hydrobromide
Active Ingredient(s): 4; 15; 7.5    mg/5mL; mg/5mL; mg/5mL & nbsp;   Brompheniramine Maleate, Phenylephrine Hydrochloride, Dextromethorphan Hydrobromide
Administration Route(s): ORAL
Dosage Form(s): LIQUID
Coding System: National Drug Codes(NDC)

Labeler Information of ALAHIST

Product NDC: 50991-814
Labeler Name: Poly Pharmaceuticals, Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number: part341
Marketing Category: OTC MONOGRAPH FINAL
Start Marketing Date: 20071227

Package Information of ALAHIST

Package NDC: 50991-814-15
Package Description: 12 BOTTLE in 1 TRAY (50991-814-15) > 15 mL in 1 BOTTLE

NDC Information of ALAHIST

NDC Code 50991-814-15
Proprietary Name ALAHIST
Package Description 12 BOTTLE in 1 TRAY (50991-814-15) > 15 mL in 1 BOTTLE
Product NDC 50991-814
Product Type Name HUMAN OTC DRUG
Non Proprietary Name Brompheniramine Maleate, Phenylephrine Hydrochloride, Dextromethorphan Hydrobromide
Dosage Form Name LIQUID
Route Name ORAL
Start Marketing Date 20071227
Marketing Category Name OTC MONOGRAPH FINAL
Labeler Name Poly Pharmaceuticals, Inc.
Substance Name BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE
Strength Number 4; 15; 7.5
Strength Unit mg/5mL; mg/5mL; mg/5mL
Pharmaceutical Classes

Complete Information of ALAHIST


General Information